Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents

(2015) Fernando Alfonso et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus

(2015) Lutz Fischer et al.   TRANSPLANTATION

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex

(2013) Darcy A. Krueger et al.   ANNALS OF NEUROLOGY

Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86

(2013) Mehmet Canpolat et al.   CHILDS NERVOUS SYSTEM

A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease

(2013) Flavio Ribichini et al.   JACC-Cardiovascular Interventions

A Novel Topical Rapamycin Cream for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex

(2013) James W. Wheless et al.   JOURNAL OF CHILD NEUROLOGY

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

(2013) John J Bissler et al.   LANCET

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

(2013) Hope Northrup et al.   PEDIATRIC NEUROLOGY

Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex

(2013) Mary Kay Koenig et al.   Drugs in research & development

A Novel Application of Topical Rapamycin Formulation, an Inhibitor of mTOR, for Patients With Hypomelanotic Macules in Tuberous Sclerosis Complex

(2012) Mari Wataya-Kaneda   ARCHIVES OF DERMATOLOGY

Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis

(2012) David Neal Franz et al.   Current Neurology and Neuroscience Reports

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

(2012) D. Castellano et al.   ONCOLOGIST

Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients

(2011) Rachael S Foster et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial

(2011) D. M. Davies et al.   CLINICAL CANCER RESEARCH

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

(2011) Marianne E Pavel et al.   LANCET

Regression of a Cardiac Rhabdomyoma in a Patient Receiving Everolimus

(2011) D. Tiberio et al.   PEDIATRICS

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease

(2011) Sandra L. Dabora et al.   PLoS One

Phase 3 trial of everolimus for metastatic renal cell carcinoma

(2010) Robert J. Motzer et al.   CANCER

Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex

(2010) Michal Yalon et al.   CHILDS NERVOUS SYSTEM

Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex

(2010) Ala Birca et al.   Journal of Neurosurgery-Pediatrics

Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex

(2010) R. Peces et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

(2010) Darcy A. Krueger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optic Nerve Tumor in Tuberous Sclerosis Complex is not Responsive to Sirolimus

(2010) Steven P. Sparagana et al.   PEDIATRIC NEUROLOGY

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders

(2010) Dan Ehninger et al.   TRENDS IN MOLECULAR MEDICINE

Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors

(2009) Catherine Lam et al.   PEDIATRIC BLOOD & CANCER

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Are cortical tubers epileptogenic? Evidence from electrocorticography

(2008) Philippe Major et al.   EPILEPSIA

Behavior problems in children with tuberous sclerosis complex and parental stress

(2008) Claudine M.C. Kopp et al.   EPILEPSY & BEHAVIOR

Regression of Subependymal Giant Cell Astrocytoma With Rapamycin in Tuberous Sclerosis Complex

(2008) Mary Kay Koenig et al.   JOURNAL OF CHILD NEUROLOGY

Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

(2008) John J. Bissler et al.   NEW ENGLAND JOURNAL OF MEDICINE

The pathogenesis and imaging of the tuberous sclerosis complex

(2008) Henry J. Baskin   PEDIATRIC RADIOLOGY

Mechanisms of Epileptogenesis in Tuberous Sclerosis Complex and Related Malformations of Cortical Development with Abnormal Glioneuronal Proliferation

(2007) Michael Wong   EPILEPSIA